Feb 18, 2021
By Jane Brown
Health Canada decision makers are taking more time on whether to move forward on approving the AstraZeneca COVID-19 vaccine, after signalling two weeks ago the ruling could be imminent.
Now there is a suggestion Johnson and Johnson’s candidate will be the third vaccine approved for use in Canada, in addition to Moderna’s and the vaccine by Pfizer BioNTech.
The AstraZeneca vaccine has been authorized by more than two-dozen jurisdictions, with both the United States and the European Medicines Agency expected to make their decisions in coming weeks.
There are concerns there is not enough data to ensure the AstraZeneca vaccine is effective in people over 65, maybe even over 55.
However on Wednesday, staff at the World Health Organization gave approval to the AstraZeneca shot.